Medical Equipment

One of the Major Drivers of the Immunoassay Market Is the Rising Infectious And Chronic Diseases Drive Immunoassay Market Growth

March 12, 2026March 18, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Large Is The Immunoassay Market Projected To Become By 2030 Based On Its 2026 Valuation?

The immunoassay market has shown substantial expansion in recent years. Its valuation is anticipated to rise from $37.32 billion in 2025 to $40.07 billion in 2026, progressing at a compound annual growth rate (CAGR) of 7.4%. This historical growth can be attributed to the increasing incidence of infectious and chronic conditions, a surge in clinical laboratory testing volumes, the extensive embrace of ELISA-based diagnostics, the broadening scope of pharmaceutical research efforts, and the escalating demand for prompt disease detection.

The immunoassay market size is projected to experience robust growth in the upcoming years. It is set to expand to $52.83 billion in 2030, achieving a compound annual growth rate (CAGR) of 7.2%. This increase during the forecast period can be attributed to factors such as the escalating demand for rapid diagnostics, greater investments in personalized medicine, the expansion of decentralized testing models, the increasing adoption of digital laboratory workflows, and a heightened focus on companion diagnostics. Significant trends anticipated within the same timeframe include the growing acceptance of high-sensitivity immunoassay kits, the rising deployment of automated immunoassay analyzers, an increasing need for point-of-care immunoassay testing, the expansion of multiplex immunoassay platforms, and improved integration of data management software.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9838&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The Immunoassay Market?

The growing incidence of infectious and chronic diseases is projected to fuel the expansion of the immunoassay market in the future. These conditions encompass illnesses stemming from pathogens or enduring health issues necessitating continuous oversight, identification, and care. Their rise is attributed to heightened exposure to environmental contaminants, which compromises immune systems and elevates disease vulnerability. Consequently, the immunoassay market is experiencing higher demand, driven by the swift increase in these illnesses, prompting businesses to integrate sophisticated diagnostic instruments for prompt detection, disease monitoring, and precise clinical judgments. For example, the UK Health Security Agency (UKHSA), a public health body based in the United Kingdom, reported in June 2025 that Campylobacter cases in England escalated from 60,055 in 2023 to 70,352 in 2024. This represented an increase of 10,297 cases, or 17.1%, with the reporting rate climbing from 104.1 to 121.9 per 100,000 population. Thus, the growing prevalence of infectious and chronic illnesses is fueling the demand within the immunoassay market.

What Segment Groups Are Identified Within The Immunoassay Market?

The immunoassay market covered in this report is segmented –

1) By Product: Reagents And Kits, Analyzers Or Instruments, Software And Services

2) By Specimen: Blood, Saliva, Urine, Other Specimens

3) By Application: Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications

4) By End User: Research And Academic Laboratories, Pharmaceutical And Biotechnology Companies And CROs, Hospitals And Clinics, Clinical Laboratories

Subsegments:

1) By Reagents And Kits: ELISA Kits, Rapid Test Kits, Control Reagents, Assay Development Reagents

2) By Analyzers Or Instruments: Automated Analyzers, Point-Of-Care Testing Devices, Microplate Readers, Luminometers

3) By Software And Services: Data Management Software, Analytical Software, Support And Maintenance Services, Consulting Services

What Trends Are Advancing Progress In The Immunoassay Market?

Leading companies in the immunoassay market are introducing advanced immunoassay analyzers to gain a competitive advantage. Immunoassay analyzers are sophisticated laboratory instruments designed to automate and streamline the detection and measurement of biological molecules, such as proteins or hormones, by employing immunological reactions. For instance, in May 2023, Beckman Coulter Diagnostics, a US-based company specializing in products that simplify, automate, and innovate complex biomedical testing, launched its DxI 9000 Access Immunoassay Analyzer. The DxI 9000 Access Immunoassay Analyzer is engineered to fulfill clinical laboratories’ needs for speed, reliability, reproducibility, quality, and an expanded test menu. It has demonstrated the ability to develop increasingly sensitive and clinically relevant assays, enhancing the effect of new pharmaceutical treatments and ultimately improving patient outcomes. This system incorporates innovations such as new analyte processing and detection technology, precision sensors, smart algorithms, and remote real-time system monitoring, and stands out as the only immunoassay analyzer system requiring no daily maintenance.

Which Companies Hold Significant Positions In The Immunoassay Market?

Major companies operating in the immunoassay market are Siemens Healthineers GmbH, bioMérieux, Abbott, Beckman Coulter Inc., Quidel Corporation, Ortho Clinical Diagnostics, Sysmex Corporation, Bio-Rad Laboratories Inc., Becton Dickinson and Company, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., PerkinElmer Inc, WAK-Chemie Medical GmbH, J Mitra & Co Pvt Ltd, Kamiya Biomedical Company, Tosoh Corporation, Gyros Protein Technologies AB, BioCheck Inc., Bio-Techn, DiaSorin S.p.A, Meso Scale Diagnostics LLC, QIAGE, Randox Laboratories Ltd., Shenzhen Mindray Bio-Medical Electronics Co Ltd, Danaher Corporation, Hologic Inc., Tecan Trading AG, Eurofins Scientific, Abcam plc, Enzo Biochem Inc., Luminex Corporation, Quanterix Corporation, Roche Diagnostics, ZEUS Scientific Inc.

Read the full immunoassay market report here:

https://www.thebusinessresearchcompany.com/report/immunoassay-global-market-report

Which Regions Are Projected To Dominate The Immunoassay Market In The Coming Years?

North America was the largest region in the immunoassay market in 2025. Asia-Pacific is expected to be the fastest-growing region in the immunoassay market report during the forecast period. The regions covered in the immunoassay market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Immunoassay Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9838&type=smp

Browse Through More Reports Similar to the Global Immunoassay Market 2026, By The Business Research Company

Immunohematology Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report

Immunomodulator Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunomodulator-global-market-report

Immune Health Supplements Market Report 2026

https://www.thebusinessresearchcompany.com/report/immune-health-supplements-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795